Sof foyda bo'yicha sotuv rentabelligi: ANI Pharmaceuticals Inc (ANIP)

ANI Pharmaceuticals, Inc. (ANIP) tovar belgisi

Generik dori vositalariga nisbatan narxlar bosimi va xomashyo inflyatsiyasi ANI Pharmaceuticals (ANIP) kompaniyasining foydasini cheklamoqda. Biroq, murakkab texnik jarayonlar va FDA nazorati mustahkam himoya to'sig'ini yaratadi. Sof foyda marjasi tendentsiyasi ushbu tebranishlarni aniq aks ettiradi, bunda parametr qiymati 10.40 ga tengdir. Biznes barqarorligi boshqaruv chaqqonligini va ortiqcha byurokratiyaning yo'qligini qadrlaydigan jipslashtirilgan tadqiqot xodimlari tomonidan qo'llab-quvvatlanadi.

ANI Pharmaceuticals Corp (ANIP) Sof foyda marjasi: 04.07.2022 - 19.11.2026 davri uchun

ANIP (ANI Pharmaceuticals Corp): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning jamlanma tahliliyoti:ANI Pharmaceuticals
ANI Pharma yetakchi tovari

Investitsiya risklarini minimallashtirish uchun daromadni sof foydaga aylantirish samaradorligini baholash juda muhimdir. Umumiy savdo hajmining sof foydaga nisbati sifatida hisoblanadigan ushbu ko'rsatkich ANI Pharmaceuticals (ANIP) kompaniyasining sof marja koeffitsienti orqali ifodalanadi va u portfelni faol kengaytirish davrida kompaniyaning generik va orfan dori vositalaridan maksimal qiymat olish qobiliyatini namoyish etadi.

Asosiy raqobatchilar

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sof marja Ligand (LGND)|Sotuvning sof marjinal rentabelligi amneal.com (AMRX)|Sotuvning sof marjinal rentabelligi PRGO (perrigo.com)|Alvotech SA (ALVO) - Sof marja|Liquidia Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Galapagos Corp (GLPG)|MNKD: Sotuvning sof marjinal rentabelligi|amphastar.com (AMPH) - Sotuvning sof marjinal rentabelligi|PCRX (Pacira Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ARS Pharmaceuticals, Inc. (SPRY)|Sotuvning sof marjinal rentabelligi TBPH|AQST (Aquestive Therapeutics) - Sof foyda normasi|scPharmaceuticals, Inc. - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi TECX|tonixpharma.com - Sotuvning sof marjinal rentabelligi|Sof foyda normasi SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi BioHarvest|Sof foyda bo'yicha sotuv rentabelligi EXOZ|Sof foyda bo'yicha sotuv rentabelligi Oramed Pharmaceuticals (ORMP)|Sof foyda bo'yicha sotuv rentabelligi ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi ABVC (ABVC BioPharma Inc)|CPIX - Sof foyda bo'yicha sotuv rentabelligi|Quantum BioPharma Corp - Sotuvning sof marjinal rentabelligi|FGEN (fibrogen.com) - Sotuvning sof rentabelligi|TELO (Telomir Pharmaceuticals) - Sof foyda bo'yicha sotuv rentabelligi|Rani Therapeutics Holdings - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi SNYR|Sof marja rallybio.com RLYB|Sotuvning sof marjinal rentabelligi LEXX|PULM (Pulmatrix, Inc.) - Sof foyda normasi|Pheton Holdings - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Aptorum Group Limited APM|LYRA: Sof foyda bo'yicha sotuv rentabelligi|IBO: Sof marja|TNFA: Sotuvning sof marjinal rentabelligi|YCBD: Kompaniyaning sof rentabelligi|Sof marja PainReform Ltd|CYTO (altamiratherapeutics.com) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma